Semax Half-Life: How Long Does Semax Last?

Semax has a reported plasma half-life of roughly 12 to 30 minutes (0.2 to 0.5 hours), making it one of the shorter-acting research peptides. This means the compound is cleared from the bloodstream quickly, so its effects are typically short-lived unless it is dosed repeatedly or delivered in a sustained-release formulation. How long semax lasts in the body depends on the route of administration, individual metabolism, and other factors.

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) fragment 4–10. It is not FDA-approved for human use in the United States, though it is approved as a prescription drug in Russia. Most available information comes from laboratory and animal studies, so any discussion of its half-life should be treated as preliminary.

What Is Semax and Why Does Its Half-Life Matter?

Semax is studied for its potential effects on cognition, attention, and neuroprotection. Its short half-life matters because it determines how often a dose must be repeated to maintain blood levels. A peptide with a 15-minute half-life will be eliminated much faster than one with a multi-hour or multi-day half-life.

For researchers, the semax half life is a key pharmacokinetic parameter. It helps estimate clearance, dosing intervals, and detection windows in biological samples. It also explains why intranasal and subcutaneous routes are common in studies—they deliver the peptide quickly before enzymatic degradation occurs.

How Long Does Semax Last? The Reported Half-Life

Published data on semax suggest a plasma half-life of approximately 0.2 to 0.5 hours after intravenous or intranasal administration. Some sources report values closer to 0.5 to 1 hour, but the consensus is that semax is rapidly degraded by peptidases in the blood and tissues.

How long does semax last in practical terms? If the half-life is 20 minutes, then roughly half of the dose is gone within 20 minutes, three-quarters within 40 minutes, and over 90% within about 70 minutes. Effects on brain activity may last somewhat longer because the peptide can cross the blood–brain barrier and interact with target receptors, but the plasma half-life remains short.

Factors That Affect Semax Half-Life

Several variables can change how quickly semax is cleared:

• Route of administration: Intravenous delivery produces the shortest apparent half-life because the peptide enters the bloodstream directly. Intranasal and subcutaneous routes may show slightly different profiles due to absorption rates.
• Enzymatic activity: Peptidases in plasma and tissues break down semax. Individual differences in enzyme levels can affect clearance.
• Dose and formulation: Higher doses or modified formulations (such as liposomal or sustained-release versions) can extend the presence of the peptide.
• Liver and kidney function: These organs help eliminate peptides and their metabolites, so impairment may slow clearance.
• Species differences: Most pharmacokinetic data come from animal models, which may not perfectly predict human half-life.

How Semax Compares to Other Peptides

Semax is not the only peptide with a short half-life. Many research peptides are cleared within minutes to hours, while some are designed to last for days. Understanding these differences helps researchers interpret study results and design dosing protocols.

For context, the cjc 1295 no dac half-life is only about 30 minutes, similar in scale to semax. The aod 9604 half-life is reported at roughly 2.5 hours, and the somatropin half-life is typically 2 to 3 hours after subcutaneous injection. By contrast, the tirzepatide half-life is about 5 days, which is a completely different order of magnitude. Researchers also note that the melanotan ii half life is around 1 hour, placing it between semax and longer-acting peptides like tirzepatide.

The table above shows that semax sits at the very short end of the peptide half-life spectrum. This short duration is a major reason why repeated dosing is often discussed in research settings.

How Long Does Semax Last in the Body? Detection and Testing

Because semax is cleared so quickly, detecting it in blood or urine is challenging. Standard drug tests do not screen for semax, and there are no widely available commercial assays for human use. If testing is performed, it usually requires specialized mass spectrometry methods and a sample collected very soon after administration.

How long semax lasts in the body for detection purposes is not well established. The short plasma half-life suggests that parent peptide levels drop below detectable limits within a few hours, but metabolites might persist longer. No official detection window has been published for humans.

Safety, Legal Status, and What to Know

Semax is not approved by the FDA for human use in the United States. It is sold as a research chemical, and its safety profile in humans is not fully characterized. Reported side effects from limited studies include headache, dizziness, and irritation at the site of administration.

Anyone considering semax should consult a healthcare professional. This article is for informational purposes only and does not constitute medical advice. Peptides obtained online may be impure or mislabeled, which adds additional risk.

Key Takeaways

• Semax has a short plasma half-life of approximately 12 to 30 minutes.
• How long semax lasts depends on the route of administration and individual metabolism.
• Semax is not FDA-approved for human use in the United States.
• Compared with peptides like tirzepatide, semax is cleared extremely quickly.
• No standard detection window exists for semax in humans.

Understanding the semax half-life is essential for interpreting research and designing studies, but it does not imply that semax is safe or effective for any human condition.